Some drugs may have Authority Required (Streamlined) status which does not require an explicit approval from Medicare, instead the doctor can use the Authority code found in the published Schedule for a given drug/indication. The maximum daily dose of this product is equivalent to 51.15% of the WHO recommended maximum daily intake for sodium.

Gaviscon for gastro-oesophageal reflux disease – Medicines Gaviscon for gastro-oesophageal reflux disease – Medicines

Not to be used when treating infants with known or suspected impairment of renal function as the sodium content (approximately 23.9 mg or 1.04 mmol per dose) may add to the risk of hypernatraemia. The medicinal product is a combination of two antacids (calcium carbonate and sodium bicarbonate) and an alginate.

Mix Gaviscon powder (for babies and children under 2) with cool, boiled water or formula milk. Dosage For babies weighing more than 4.5 kg (10 lb), mix the right amount of powder into at least 225 mL of formula feed.

Gaviscon | Superdrug Gaviscon | Superdrug

Pharmacotherapeutic classification: A02BX, other drugs for peptic ulcer and gastro-oesophageal reflux disease.

Pharmacy product

Hypernatraemia should be treated with oral fluids and monitoring of the infant's electrolytes. Severe cases should be treated by the cautious use of hypo-osmotic solutions.